✦ LIBER ✦

Thromboembolism in pediatric inflammatory bowel disease: Systematic review

✍ Scribed by Marzia Lazzerini; Matteo Bramuzzo; Massimo Maschio; Stefano Martelossi; Alessandro Ventura

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 191 KB
Volume: 17
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21563

No coin nor oath required. For personal study only.

✦ Synopsis

Background: Several studies suggest an increased risk of venous and arterial thromboembolism (TE) in adults with inflammatory bowel disease (IBD) compared to the general population. We performed a systematic review of studies on incidence and characteristic of TE in children with IBD.

Methods: We searched Medline, LILACS, EMBASE, POP-LINE, CINHAL, and reference lists of identified articles, without language restrictions, in August 2010.

Results: Population studies suggest that there is an increased risk of TE in children with IBD compared to controls. TE occurred in children with IBD in all age ranges, mostly (82.8%) during active disease, and more frequently in children with ulcerative colitis (odds ratio [OR] 3.7, 95% confidence interval [CI] 1.8-7.6). At least one specific risk factor for TE was recognized in 50% of cases; two risk factors were present in 24%. Out of 92 published cases of TE in children with IBD, 54.3% occurred in cerebral site, 26% in the limbs, 13% in the abdominal vessels, and the remaining in the retina and lungs. After a first episode of TE, an early recurrence was observed in 11.4% of children, a late recurrence in 10%. A number of different therapeutic schemes were used. Overall mortality was 5.7% and was mostly associated with cerebral TE.

Conclusions: Population studies are needed to clarify the risk of TE in children with IBD, the relative weight of other risk factors, the characteristics of the events, and to define guidelines of therapy and prophylaxis.

📜 SIMILAR VOLUMES

Cerebral thromboembolic events in pediat

Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease

✍ A.R. Barclay; J.M. Keightley; I. Horrocks; V. Garrick; P. McGrogan; R.K. Russell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

## Background: There is a recognized association between pediatric inflammatory bowel disease (ibd) and cerebral thromboembolic events (ctes). historical reporting had described the association as strongest between ulcerative colitis (uc), rather than crohn's disease (cd). we describe the incidence

Epidemiology of pediatric inflammatory b

Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends

✍ Eric I. Benchimol; Kyle J. Fortinsky; Peter Gozdyra; Meta Van den Heuvel; Johan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 1 views

Background: Temporal trends in the incidence of pediatriconset inflammatory bowel disease (IBD) are controversial and a wide range of estimates have been reported worldwide. We conducted a systematic review of research describing the epidemiology of childhood-onset IBD to assess changes in incidence

Inflammatory bowel disease and African A

Inflammatory bowel disease and African Americans: A systematic review

✍ Suhal S. Mahid; Aaron M. Mulhall; Ryan D. Gholson; M. Robert Eichenberger; Susan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Background: Inflammatory bowel disease (ibd) is comprised of crohn's disease (cd) and ulcerative colitis (uc). there are conflicting reports on whether african americans have a more severe disease course, presentation, and more frequent extraintestinal manifestations (eim). we examined the preci

Inflammatory bowel disease-associated th

Inflammatory bowel disease-associated thromboembolism: A systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis

✍ James H. Tabibian; Michael B. Streiff 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

Background: Thromboembolism (TE) is a common extraintestinal complication of inflammatory bowel disease (IBD). Catheter-directed thrombolysis (CDT) is being increasingly used to treat TE but often evokes fears of hemorrhagic complications (HCs) in patients with IBD. We reviewed clinical outcomes wit

5-Aminosalicylates and renal function in

5-Aminosalicylates and renal function in inflammatory bowel disease: A systematic review

✍ Javier P. Gisbert; Yago González-Lama; José Maté 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

Nephrotoxicity has been described in some patients with inflammatory bowel disease (IBD) treated with 5-aminosalicylic acid (5-ASA). Studies with 5-ASA treatment in which serum creatinine or creatinine clearance was measured regularly show that nephrotoxicity is exceptional (mean rate of only 0.26%

Pediatric inflammatory bowel disease: Cl

Pediatric inflammatory bowel disease: Clinical and molecular genetics

✍ Vincent Biank; Ulrich Broeckel; Subra Kugathasan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Pediatric-onset inflammatory bowel disease (IBD) is characterized by distinct phenotypic differences compared to adult-onset IBD. This raises the question whether early (pediatric) onset IBD represents the same disease process occurring in adults but merely at an earlier age or does IBD in children